Mazdutide demonstrates significant weight loss efficacy and multiple metabolic benefits
The 48-week outcomes from a Phase 2 clinical study of higher dose (9mg) mazdutide in Chinese subjects with obesity have demonstrated...
top of page
Browse by category
Search
Low adherence and increased cost in first year of taking GLP-1a drugs for weight loss
An analysis of real-world integrated pharmacy and medical claims data by leading pharmacy benefit manager Prime Therapeutics and Magellan...
ASA’s Task Force: Stop taking GLP-1 medications for diabetes and weight loss before elective surgery
With the growing popularity of medications like Ozempic (semaglutide), Trulicity (dulaglutide) and other glucagon-like peptide-1 (GLP-1)...
Journal Watch 11/05/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. as ever, we have...
GLP-1 analogues can actually restore anticancer NK immune cells
Researchers from the Londsdale Health Institute at Maynooth University, have found that glucagon-like peptide (GLP-1) analogues, can...
Browse by tag
bottom of page